IPOLICY SOLUTIONS

H.R.5269/S.2761 - RESULTS Act Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P) CY 2027 Payment Policies under the Medicare Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies (CMS-1848-P)

Client expense: — · Firm income: $70,500

Matched citations: S.2761

HR 8792/S.4513: Multigenerational Caregivers Data Act HR 6766/S3492: Essential Caregivers Act HR 2036/S 925 Credit for Caring Act Docket No. FDA-2026-P-3666-0001: Requests that the FDA codify, regularize, and transparently administer a principle the Agency already recognizes in practice: that the adequacy of an investigation in rare diseases cannot be determined by default assumptions alone. It does not ask FDA to invent a new principle or apply distinct evidentiary thresholds or concessions to rare disease research programs. Drug Repurposing for Unmet Medical Needs; Request for Information (FDA-2026-N-4492) Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comment (FDA-2026-N-3947)

Client expense: — · Firm income: $45,000

Matched citations: HR 2036

HR 2036 HEALTHY BRAINS Act NOT-OD-26-047: Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for Fiscal Years 2027-2031

Client expense: — · Firm income: $45,000

Matched citations: HR 2036

HR 8792/S.4513: Multigenerational Caregivers Data Act HR 6766/S3492: Essential Caregivers Act HR 2036/S 925 Credit for Caring Act Docket No. FDA-2026-P-3666-0001: Requests that the FDA codify, regularize, and transparently administer a principle the Agency already recognizes in practice: that the adequacy of an investigation in rare diseases cannot be determined by default assumptions alone. It does not ask FDA to invent a new principle or apply distinct evidentiary thresholds or concessions to rare disease research programs. Drug Repurposing for Unmet Medical Needs; Request for Information (FDA-2026-N-4492) Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comment (FDA-2026-N-3947)

Client expense: — · Firm income: $45,000

Matched citations: HR 6766

HR 8792/S.4513: Multigenerational Caregivers Data Act HR 6766/S3492: Essential Caregivers Act HR 2036/S 925 Credit for Caring Act Docket No. FDA-2026-P-3666-0001: Requests that the FDA codify, regularize, and transparently administer a principle the Agency already recognizes in practice: that the adequacy of an investigation in rare diseases cannot be determined by default assumptions alone. It does not ask FDA to invent a new principle or apply distinct evidentiary thresholds or concessions to rare disease research programs. Drug Repurposing for Unmet Medical Needs; Request for Information (FDA-2026-N-4492) Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comment (FDA-2026-N-3947)

Client expense: — · Firm income: $45,000

Matched citations: HR 8792

H.R.9260: Labor, Health and Human Services, Education, and Related Agencies FY 2027 No bill number, Senate: Defense FY 2027

Client expense: — · Firm income: $45,000

Matched citations: H.R.9260

HR 8792/S.4513: Multigenerational Caregivers Data Act HR 6766/S3492: Essential Caregivers Act HR 2036/S 925 Credit for Caring Act Docket No. FDA-2026-P-3666-0001: Requests that the FDA codify, regularize, and transparently administer a principle the Agency already recognizes in practice: that the adequacy of an investigation in rare diseases cannot be determined by default assumptions alone. It does not ask FDA to invent a new principle or apply distinct evidentiary thresholds or concessions to rare disease research programs. Drug Repurposing for Unmet Medical Needs; Request for Information (FDA-2026-N-4492) Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comment (FDA-2026-N-3947)

Client expense: — · Firm income: $45,000

Matched citations: S3492

HR 8792/S.4513: Multigenerational Caregivers Data Act HR 6766/S3492: Essential Caregivers Act HR 2036/S 925 Credit for Caring Act Docket No. FDA-2026-P-3666-0001: Requests that the FDA codify, regularize, and transparently administer a principle the Agency already recognizes in practice: that the adequacy of an investigation in rare diseases cannot be determined by default assumptions alone. It does not ask FDA to invent a new principle or apply distinct evidentiary thresholds or concessions to rare disease research programs. Drug Repurposing for Unmet Medical Needs; Request for Information (FDA-2026-N-4492) Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comment (FDA-2026-N-3947)

Client expense: — · Firm income: $45,000

Matched citations: S.4513

HR 8792/S.4513: Multigenerational Caregivers Data Act HR 6766/S3492: Essential Caregivers Act HR 2036/S 925 Credit for Caring Act Docket No. FDA-2026-P-3666-0001: Requests that the FDA codify, regularize, and transparently administer a principle the Agency already recognizes in practice: that the adequacy of an investigation in rare diseases cannot be determined by default assumptions alone. It does not ask FDA to invent a new principle or apply distinct evidentiary thresholds or concessions to rare disease research programs. Drug Repurposing for Unmet Medical Needs; Request for Information (FDA-2026-N-4492) Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comment (FDA-2026-N-3947)

Client expense: — · Firm income: $45,000

Matched citations: S 925

H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025

Client expense: — · Firm income: $82,500

Matched citations: H.R.6624

H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025

Client expense: — · Firm income: $82,500

Matched citations: S.3452

S.3741 - Biosecurity Modernization and Innovation Act of 2026

Client expense: — · Firm income: $82,500

Matched citations: S.3741

H.R.3152/S.1546: Patent Eligibility Restoration Act

Client expense: — · Firm income: $70,500

Matched citations: H.R.3152

H.R.5269/S.2761 - RESULTS Act

Client expense: — · Firm income: $70,500

Matched citations: H.R.5269

H.R. 8890: Enhancing CLIA Act of 2026

Client expense: — · Firm income: $70,500

Matched citations: H.R. 8890

H.R.3152/S.1546: Patent Eligibility Restoration Act

Client expense: — · Firm income: $70,500

Matched citations: S.1546

H.R.5269/S.2761 - RESULTS Act

Client expense: — · Firm income: $70,500

Matched citations: S.2761

H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025

Client expense: — · Firm income: $82,500

Matched citations: H.R.6624

H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025

Client expense: — · Firm income: $82,500

Matched citations: S.3452

S.3741 - Biosecurity Modernization and Innovation Act of 2026

Client expense: — · Firm income: $82,500

Matched citations: S.3741

H.R.3152/S.1546: Patent Eligibility Restoration Act

Client expense: — · Firm income: $70,500

Matched citations: H.R.3152